Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Ishares Msci Italy ETF (EWI) Price & Performance

Adaptive Biotechnologies CorpTrade
Ishares Msci Italy ETFTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Ishares Msci Italy ETF — how do they compare? Adaptive Biotechnologies Corp trades at $25.45 (market cap $4.04B), while Ishares Msci Italy ETF trades at $63.37. Which is the better fit depends on your goals.

ADPTEWI
Market Cap
$4.04B
Sector
HealthBroad Market / Factor
52-Week High
$25.45$63.35
52-Week Low
$12.30$50.31
Enterprise Value
$4.10B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adaptive Biotechnologies Corp

ADPT trades at $25.45, up 2.09% today, near its 52-week high. The stock shows bullish technical signals with support at $25 and resistance at $26. Revenue growth accelerated to $277M in 2025, though net losses persist. Recent news highlights a strategic separation of its MRD and Immune Medicine businesses, aiming to unlock value.

Outlook is cautiously optimistic with 65% analyst buy ratings and a $25.50 price target. Key opportunities include MRD segment profitability and separation benefits, while risks involve sustained losses, competitive pressures, and execution challenges in the business split.

Ishares Msci Italy ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Ishares Msci Italy ETF

EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.

Read more on EWI